Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lara Kunschner Ronan"'
Autor:
Paula K. Rauschkolb, Lara Kunschner Ronan, Shodeinde Coker, Sivraj Muralikrishnan, Keisuke Shirai
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 43-48 (2020)
Case Reports in Oncology
Case Reports in Oncology
Immunotherapy has improved outcomes in many malignancies, most notably in melanoma, lung cancer, and bladder cancer. Understanding the side effects associated with these medications is an important part of managing our patients. Although fatigue, ras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c32659d6a31a09a9fd409a9a9279e62
https://www.karger.com/Article/FullText/504930
https://www.karger.com/Article/FullText/504930
Autor:
Lara Kunschner Ronan
Publikováno v:
Neurology. 91:183-184
I met Mary shortly after she was diagnosed with glioblastoma multiforme at age 54. It was easy to like her; she was stylish, well-spoken, and athletic. Her effortless manner and engaging smile charmed me into nearly mistaking her for an old friend in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7e05c080a1702a48d41c23b59c69296
https://doi.org/10.1212/wnl.0000000000005852
https://doi.org/10.1212/wnl.0000000000005852
Autor:
Jennifer Hong, Katherine Thorley, Lanelle Jalowiec, Natalie B.V. Riblet, Nancy L. Kennedy, Melissa C. Davis, David Nalepinski, Evelyn Schlosser, Linda P. Mason, Tobi J. Cooney, Camilo E. Fadul, Lara Kunschner Ronan, Jennifer Snide, Sabrina Richie
Publikováno v:
Neuro-oncology practice. 3(3)
BackgroundPatients with glioma are at increased risk for tumor-related and treatment-related complications. Few guidelines exist to manage complications through supportive care. Our prior work suggests that a clinical care pathway can improve the car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232f465be1817d71fc92d10e97e8760c
https://pubmed.ncbi.nlm.nih.gov/31386082
https://pubmed.ncbi.nlm.nih.gov/31386082
Voltage gated potassium channel complex antibody (VGKC Ab) has been associated with many neurological illnesses including seizures. VGKC Ab related seizures are less responsive to antiepileptic drugs alone, and often require immunosuppression to achi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac22f095d0461ff793b8924d0c5b8bb
https://europepmc.org/articles/PMC4218217/
https://europepmc.org/articles/PMC4218217/
Publikováno v:
Journal of Clinical Oncology. 34:33-33
33 Background: Diagnosis of malignant glioma is catastrophic and standard treatment options remain non-curative. Patients are not guaranteed a good outcome, have significantly decreased QOL and exposure to risk. Shared decision making, is believed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8638380e65dec2177cf04a77eb35263
https://doi.org/10.1200/jco.2016.34.26_suppl.33
https://doi.org/10.1200/jco.2016.34.26_suppl.33
Autor:
Lara Kunschner Ronan
Publikováno v:
Academic Medicine. 90:1269
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d2a1755439ae172cab7e07b6782fea
https://doi.org/10.1097/acm.0000000000000813
https://doi.org/10.1097/acm.0000000000000813
Publikováno v:
Journal of Clinical Oncology. 33:2063-2063
2063 Background: Standard treatment pathways exist for malignant glioma, but are largely palliative. Patients face difficult non-curative treatment decisions. Oncologists may misinterpret patient g...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::305ee2d07ba0e7e261031cef496f45b4
https://doi.org/10.1200/jco.2015.33.15_suppl.2063
https://doi.org/10.1200/jco.2015.33.15_suppl.2063
Autor:
Sabrina Powers, Linda P. Mason, Katherine Thorley, Lara Kunschner Ronan, Tobi J. Cooney, Jennifer Snide, Nancy L. Kennedy, Evelyn Schlosser, Natalie B.V. Riblet, Lanelle Jalowiec, Camilo E. Fadul, David Nalepinski
Publikováno v:
Journal of Clinical Oncology. 32:217-217
217 Background: Gliomas account for nearly 80% of primary malignant brain tumors and are associated with poor survival. Developing clinical care pathways to ensure that patients receive coordinated, comprehensive and timely care may result in improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec21bf198b810756d879568d3c3a9f1
https://doi.org/10.1200/jco.2014.32.30_suppl.217
https://doi.org/10.1200/jco.2014.32.30_suppl.217